AMLODIPINE-OLMESARTAN 5-40 MG

AMLODIPINE and OLMESARTAN medoxomil
$0.2762per EA

Strength

5; 40 mg/1; mg/1

NDC

33342019107

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA206884

On Market Since

10/27/2016

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price History

1W

0.0%

1M

-1.6%

3M

-8.0%

6M

-22.5%

1Y

-34.6%

3Y

-34.5%

5Y

-35.5%

All

-73.4%